Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study Of Pregnancies Exposed to UCB Antiepileptic Drugs to Determine if There is a Potential Increase in the Risk of Major Birth Defects

NCT00345475 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00345475
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00345475 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study Of Pregnancies Exposed to UCB Antiepileptic Drugs to Determine if There is a Potential Increase in the Risk of Major Birth Defects
Lead sponsor
UCB Pharma
Phase
Observational
Overall status
Completed
Start date
December 31, 2004
Completion date
May 31, 2016
Enrollment
516 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

birth defects, epilepsy, pregnancy complications, seizures